JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HANZLIK, P. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HANZLIK, P. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 10, Issue 7, 523-541, 1918
Copyright © 1918 by American Society for Pharmacology and Experimental Therapeutics


LOCAL HEMOSTATIC PROPERTIES OF COTARNINE AND SOME OTHER AGENTS

PAUL J. HANZLIK 1

1 From the Pharmacological Laboratory, Western Reserve University, Cleveland, Ohio

1. Epinephrin (1:1000 and powdered tablets containing 1 mgm.) acts as an efficient hemostatic for small and superficial wounds. The effects are temporary and somewhat variable. It seems to be ineffective for stopping venous hemorrhage.

2. Stypticin and styptol (10 per cent solutions and dry powders) are inefficient as local hemostatics, even after long periods of and repeated application. In fact, hemorrhage tends to be somewhat aggravated after the application of these agents, and styptol is irritating.

3. Epinephrin (1:1000) is a prompt and effective peripheral vasoconstrictor in the rabbit's ear, while styptol and stypticin (10 per cent solutions) are inactive and inefficient. Styptol and stypticin produce relaxation of frog's vessels, and stypticin of uterine vessels.

4. The following agents do not appear to act either as local hemostatics or peripheral vasoconstrictors; sodium phthalate 10 per cent, lung extract 100 per cent, kephalin 5 per cent and hydrastinine hydrochloride 10 per cent. With the exception of the phthalate, however, final conclusions are reserved until experiments with these drugs have been extended.

Submitted on November 15, 1917







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1918 by the American Society for Pharmacology and Experimental Therapeutics.